Epstein Secrets

d tradable processes that will not trade beyond certain pre- defined level(s). Ongoing research calibrates the model on historical data to maximize Sharpe ratio. 14 Month P/L 2011 2012 Jan 33,221 Feb 58,331 Mar -65,454 Apr 42,746 May -28,551 Jun 335 251,157 Jul 3,703 39,146 Aug 1

ategies ranging from taking, making and mean reverting on all major pairs. • FX Models With Very Successful Track Record ($10M+ +/annum), with live Sharpe ratios in excess of 7, trading more than 5 yards a day. • Prior to joining BGT in July - Bank of America Merrill Lynch, London as Systematic algori

71,655 Oct 38,311 26,333 Nov 104,477 -71,889 Dec 37,659 418,816 459,552 EFTA_R1_02106950 EFTA02707874 Live P8, Trading - Equity Pairs Alex Gerasev Experience Quanterra Advisors - Managing Director Responsible for ongoing hedge fund operations, trading, and risk management. Oversee a group of

sset classes 3.5m 1.4m 15x Equities (85%); futures (15%) o.97m (67.5% return on AUC) Positive months Negative months Best month Worst month Sharpe ratio 13 (81%) 3 (19%) o.27m -0.07M 2.67 EFTA00611846 Live Track Record - BGT Monthly Net PnL 300,000.00 250,000.00 200,000.00 150,000.0

Alex Gerasev Bounded Tradable Processes EFTA00611842 Confidentiality Information in this presentation is strictly private & confidential EFTA00611843 Bac

f gains into the strategy No Asset classes 07/2011 —10/2012 (16 months) Total net PnL Positive months Negative months Best month Worst month Sharpe ratio 3.5m 1.4m 15X Equities (85%); futures (15%) o.97m (67.5% return on AUC) 13 (81%) 3 (19%) O. 27M - 0.07M 2.67 EFTA_R1_02212457 EFTA0

Alex Gerasev Bounded Tradable Processe EFTA02725017 Confidentiality ■ Information in this presentation is strictly private & confidential EFTA_R1_02212454